Frontiers in viral hepatitis:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam [u.a.]
Elsevier
2003
|
| Ausgabe: | 1. ed. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Includes bibliographical references and indexes |
| Beschreibung: | XXVIII, 569 S. Ill., graph. Darst. |
| ISBN: | 0444509860 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV017747306 | ||
| 003 | DE-604 | ||
| 005 | 20040719 | ||
| 007 | t | ||
| 008 | 031222s2003 ne ad|| |||| 00||| eng d | ||
| 010 | |a 2003064329 | ||
| 020 | |a 0444509860 |c alk. paper |9 0-444-50986-0 | ||
| 035 | |a (OCoLC)53393579 | ||
| 035 | |a (DE-599)BVBBV017747306 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a ne |c NL | ||
| 049 | |a DE-355 | ||
| 050 | 0 | |a RC848.H43 | |
| 082 | 0 | |a 616.3/623 |2 22 | |
| 084 | |a YC 5600 |0 (DE-625)153237:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Frontiers in viral hepatitis |c ed. by Raymond F. Schinazi, ... |
| 250 | |a 1. ed. | ||
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier |c 2003 | |
| 300 | |a XXVIII, 569 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and indexes | ||
| 650 | 2 | |a Carcinome hépatocellulaire - prévention et contrôle | |
| 650 | 2 | |a Hépatite B - épidémiologie | |
| 650 | 2 | |a Hépatite C - épidémiologie | |
| 650 | 2 | |a Résistance virale aux médicaments | |
| 650 | 4 | |a Carcinoma, Hepatocellular |x prevention & control | |
| 650 | 4 | |a Drug Resistance, Viral | |
| 650 | 4 | |a Hepatitis B | |
| 650 | 4 | |a Hepatitis B |x drug therapy | |
| 650 | 4 | |a Hepatitis C | |
| 650 | 4 | |a Hepatitis C |x drug therapy | |
| 650 | 4 | |a Hepatitis, Viral | |
| 650 | 0 | 7 | |a Virushepatitis |0 (DE-588)4290453-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Virushepatitis |0 (DE-588)4290453-5 |D s |
| 689 | 0 | |C b |5 DE-604 | |
| 700 | 1 | |a Schinazi, Raymond F. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010664331&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-010664331 | ||
Datensatz im Suchindex
| _version_ | 1804130463374114816 |
|---|---|
| adam_text | CONTENTS
Preface xi
Acknowledgments xiv
Biographies xv
Contributors xix
REGULATORY ISSUES, EPIDEMIOLOGY,
AND EMERGING VIRUSES 1
Current issues in the regulation and approval of
antiviral drugs for hepatitis 3
Barbara A Styrt, Russell Fleischer, Teresa Wu, and Heidi M Jolson
Molecular and serum epidemiology of HBV and HCV infection and
the impact of antiviral agents in China 15
Xuefeng Liu and Raymond F Schinazi
New viruses and their relationship to hepatitis 35
Harvey J Alter
IMMUNOLOGY AND VACCINES 47
Virus specific CD8+ cell immune responses in acute and
chronic hepatitis B virus infection 49
George JM Webster and Geoffrey M Dusheiko
Cell mediated immunity and the outcome of HCV infection in chimpanzees 59
Chris M Walker
Adoptive immune transfer as a therapeutic approach for
persistent hepatitis B virus infection 71
Daniel Shouval
v
Frontiers in Viral Hepatitis EdbyRF Schinazi, J P Sommadossi and CM Rice, v — x
£ 2003 Elsevier B. V. All riehts reserved.
vi
Perspectives in HCV vaccine development 77
Erik Depla
VIRAL HEPATITIS B AND C INFECTIONS IN CHILDREN 87
Maternal/fetal/pediatric HBV and HCV infections 89
Richard A Schreiber
Effects of interferon treatment in children with post transfusional
chronic hepatitis B 97
Maria Pop, M Serban, L Cionca, R Costa, and C Jinca
GENETICS, PATHOLOGY AND VIRAL DIAGNOSIS 107
Effects of genotypic variations on hepatitis C virus
nonstructural protein 5B structure and activity 109
Zhi Hong, Eric B Ferrari, Angela Skelton, Jacquelyn Wright Minogue,
Weidong Zhong and Charles Lesburg
Compartmentalization of hepatitis C viral quasispecies 123
Xiaofeng Fan, Andre Castro Lyra and Adrian M DiBisceglie
In situ localization of PCR amplified hepatitis C virus RNA on
human erythrocytes 131
Susan Simon, Gabor Lotz, Fritz Kury, Brigit Reipert,
Alexander Steinkasserer, Martha M Eibl and Zsuzsa Schajf
Nucleic acid based antiviral approaches to HBV 139
HC Spangenberg and JR Wands
In vitro phenotype of HBV variants in patients with fulminant hepatitis B 157
Martina Sterneck and T Kalinina
Evaluation of three commercially available HBV viral load assays:
dynamic range, precision, and clinical utility 165
Andrea Snow, Florence Myrick, Charles Wakeford and Bruce McCreedy
i
vii
CELL SYSTEMS AND ANIMAL MODELS 173
Cell lines that allow regulated expression of
HCV proteins: principles and applications 175
Darius Moradpour, Markus H Heim, Andreas Cerny,
Charles M Rice and Hubert E Blum
Novel hepatitis C virus positive cell line derived from a chimpanzee
with chronic HCV infection 187
Borislava G Pavlova, Zsuzsa Schaffand Gerald Eder
A transgenic mouse lineage useful for testing antivirals
targeting hepatitis B virus 197
PL Marion, FH Salazar, K Liittschwager, BB Bordier, C Seeger,
MA Winters, AD Cooper and JM Cullen
Evaluation of therapies for hepatitis B virus
in the HBV transgenic SCID mouse model 211
Milind Kamkolkar, Marcia M Clayton, Shu Min Zhang,
Paul Black, Raymond F Schinazi and Mark A Feitelson
DRUG DISCOVERY AND DEVELOPMENT:
NOVEL THERAPEUTICS FOR HEPATITIS B AND C 223
Novel approaches in the management of chronic HBV infection 225
Angeline Bartholomeusz, Phillip Furman and Stephen Locarnini
Antiviral (3 L nucleosides specific for hepatitis B virus infection 245
Martin L Bryant, Edward G Bridges, Laurent Placidi, Abdesslem Faraj,
Anna Giulia Loi, Claire Pierra, Samira Benzaria, David Dukhan, Gilles Gosselin,
Jean Louis Imbach, Brenda Hernandez, Amy Juodawlkis, Bud Tennant,
Brent Korba, Paul Cote, Erika Cretton Scott, Raymond F Schinazi,
Maureen Myers and Jean Pierre Sommadossi
Toxicological study of the anti HBV agent P L thymidine 263
Edward G Bridges, Martin L Bryant, Laurent Placidi, Abdesslem Faraj,
Anna Giulia Loi, Claire Pierra, David Dukhan, Gilles Gosselin,
Jean Louis Imbach, Brenda Hernandez, Amy Juodawlkis, Bud Tennant,
Erika Cretton Scott and Jean Pierre Sommadossi
viii
Pharmacokinetics of (3 L thymidine and
p L 2 deoxycytidine in woodchucks and monkeys 271
Erika Cretton Scott, Edward G Bridges, Bud C Tennant, Amy Juodawlkis,
Gilles Gosselin, Jean Louis Imbach, Claire Pierra, David Dukhan,
Martin Bryant and Jean Pierre Sommadossi
Clevudine: A novel 1 P L nucleoside analogue in
clinical development for the treatment of HBV infection 281
George R Painter, Lawrence C Trost, M Robert Blum,
George M Szczech, and Phillip A Furman
Glucosidase/protein folding inhibitors as possible mutation proof,
anti hepatitis B C agents 301
Timothy M Block, Robert Jordan, Xuanyong Lu, Anand Mehta,
Donald Picker, Gary Jacob, Baruch S Blumberg and Raymond A Dwek
Nuclease resistant ribozymes directed against hepatitis C virus RNA
plus and minus strand inhibit viral replication of a HCV/poliovirus chimera 315
LM Blatt, KL Jensen, L Bellon, SF Jamison, PA Pavco, and DG Macejak
Mechanism of laser therapy of viral hepatitis 325
Victor Ovsiannikov
DRUG DISCOVERY AND DEVELOPMENT:
RESISTANCE AND THERAPEUTIC STRATEGIES IN HUMANS 333
Nomenclature for antiviral resistant human hepatitis B virus mutations
in the polymerase region 335
Lieven J Stuyver, Stephen A Locarnini, Anna Lok, Douglas D Richman,
William F Carman, Jules L Dienstag, Raymond F Schinazi, and the HEP DART
International Committee
Complex genotypic changes during failure of HBV nucleoside analogue therapy .. 353
Deenan Pillay, David Mutimer, Nigel Burroughs, David Cooper and Pat Cane
Lamivudine for chronic hepatitis B: Efficacy, safety, resistance,
and current treatment issues 365
Nathaniel A Brown
ix
Clinical experience and follow up with lamivudine in the Asian population 383
Ching Lung Lai, Man Fung Yuen
Impaired response to 5 mU/day interferon treatment in
African Americans with chronic hepatitis C 391
Alessandra Colantoni, Nicola De Maria and David H Van Thiel
Novel combined approaches to hepatitis C therapies 399
Markus Cornberg and Michael P Manns
Consensus + pegylated interferon 413
Jenny Heathcote
Impact of interferon alpha 2b and of combination with ribavirin
on progression of liver fibrosis in patients with chronic hepatitis C 425
Thierry Poynard, John McHutchison, Gary L Davis,
Rafael Esteban Mur, Zachary Goodman, Pierre Bedossa and
Janice Albrechtfor the FIBROVIRC Project Group
Decorin expression in chronic hepatitis C; effect of interferon alpha treatment .... 441
Ilona Kovalszky, Katalin Jdrmay, Jozsef Dudds and Zsuzsa Schaff
Preclinical and clinical development of the anti HIV,
anti HBV oxathiolane nucleoside analog emtricitabine 451
George R. Painter, Laurence T. Rimsky, Phillip A. Furman, Dennis C. Liotta,
Raymond F. Schinazi and Joseph B. Quinn
CD81 receptor expression in human cells: Implications for HC V therapeutics .... 485
Phillip M. Tharnish, Amy S. Juodawlkis,
Craig L. Hill and Raymond F. Schinazi
PREVENTION AND TREATMENT OPTIONS
FOR HEPATOCELLULAR CARCINOMA 493
Resolution of hepatic fibrosis as a consequence of
interferon therapy for hepatitis C 495
Yasushi Shiratori, Haruhiko Yoshida and Masao Omata
X
Symptomatic therapies for prevention of
hepatocellular carcinoma developing in chronic hepatitis C 515
Hiroshi Yotsuyanagi, Yuzo Miyakawa and Shiro lino
Mutations of the core gene sequence of HCV from patients
with hepatocellular carcinoma in China 531
Toshihiro Omoya, Ichiro Shimizu, Chiyo Horie, Takahiro Horie, Deng Fu Yao,
Mina Itonaga, Yoshihiro Okamura, Hirohito Honda and Susumu Ito
Characterization of hepatitis B virus X variants that are integrated and
expressed in human hepatocellular carcinomas 547
Wei Ning Chen and Chong Jin Oon
Subject index 557
Author index 567
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV017747306 |
| callnumber-first | R - Medicine |
| callnumber-label | RC848 |
| callnumber-raw | RC848.H43 |
| callnumber-search | RC848.H43 |
| callnumber-sort | RC 3848 H43 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YC 5600 |
| ctrlnum | (OCoLC)53393579 (DE-599)BVBBV017747306 |
| dewey-full | 616.3/623 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.3/623 |
| dewey-search | 616.3/623 |
| dewey-sort | 3616.3 3623 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01866nam a2200517zc 4500</leader><controlfield tag="001">BV017747306</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20040719 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">031222s2003 ne ad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2003064329</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0444509860</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-444-50986-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)53393579</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV017747306</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">ne</subfield><subfield code="c">NL</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC848.H43</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.3/623</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 5600</subfield><subfield code="0">(DE-625)153237:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Frontiers in viral hepatitis</subfield><subfield code="c">ed. by Raymond F. Schinazi, ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVIII, 569 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and indexes</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Carcinome hépatocellulaire - prévention et contrôle</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hépatite B - épidémiologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hépatite C - épidémiologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Résistance virale aux médicaments</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carcinoma, Hepatocellular</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance, Viral</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis B</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis B</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis C</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis C</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Virushepatitis</subfield><subfield code="0">(DE-588)4290453-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Virushepatitis</subfield><subfield code="0">(DE-588)4290453-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schinazi, Raymond F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010664331&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010664331</subfield></datafield></record></collection> |
| id | DE-604.BV017747306 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:21:26Z |
| institution | BVB |
| isbn | 0444509860 |
| language | English |
| lccn | 2003064329 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-010664331 |
| oclc_num | 53393579 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XXVIII, 569 S. Ill., graph. Darst. |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | Elsevier |
| record_format | marc |
| spelling | Frontiers in viral hepatitis ed. by Raymond F. Schinazi, ... 1. ed. Amsterdam [u.a.] Elsevier 2003 XXVIII, 569 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and indexes Carcinome hépatocellulaire - prévention et contrôle Hépatite B - épidémiologie Hépatite C - épidémiologie Résistance virale aux médicaments Carcinoma, Hepatocellular prevention & control Drug Resistance, Viral Hepatitis B Hepatitis B drug therapy Hepatitis C Hepatitis C drug therapy Hepatitis, Viral Virushepatitis (DE-588)4290453-5 gnd rswk-swf Virushepatitis (DE-588)4290453-5 s b DE-604 Schinazi, Raymond F. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010664331&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Frontiers in viral hepatitis Carcinome hépatocellulaire - prévention et contrôle Hépatite B - épidémiologie Hépatite C - épidémiologie Résistance virale aux médicaments Carcinoma, Hepatocellular prevention & control Drug Resistance, Viral Hepatitis B Hepatitis B drug therapy Hepatitis C Hepatitis C drug therapy Hepatitis, Viral Virushepatitis (DE-588)4290453-5 gnd |
| subject_GND | (DE-588)4290453-5 |
| title | Frontiers in viral hepatitis |
| title_auth | Frontiers in viral hepatitis |
| title_exact_search | Frontiers in viral hepatitis |
| title_full | Frontiers in viral hepatitis ed. by Raymond F. Schinazi, ... |
| title_fullStr | Frontiers in viral hepatitis ed. by Raymond F. Schinazi, ... |
| title_full_unstemmed | Frontiers in viral hepatitis ed. by Raymond F. Schinazi, ... |
| title_short | Frontiers in viral hepatitis |
| title_sort | frontiers in viral hepatitis |
| topic | Carcinome hépatocellulaire - prévention et contrôle Hépatite B - épidémiologie Hépatite C - épidémiologie Résistance virale aux médicaments Carcinoma, Hepatocellular prevention & control Drug Resistance, Viral Hepatitis B Hepatitis B drug therapy Hepatitis C Hepatitis C drug therapy Hepatitis, Viral Virushepatitis (DE-588)4290453-5 gnd |
| topic_facet | Carcinome hépatocellulaire - prévention et contrôle Hépatite B - épidémiologie Hépatite C - épidémiologie Résistance virale aux médicaments Carcinoma, Hepatocellular prevention & control Drug Resistance, Viral Hepatitis B Hepatitis B drug therapy Hepatitis C Hepatitis C drug therapy Hepatitis, Viral Virushepatitis |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010664331&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT schinaziraymondf frontiersinviralhepatitis |